Augmentation of Thrombin Generation in Neonates Undergoing Cardiopulmonary Bypass
We compared recombinant activated factor VII (rFVIIa) with three-factor prothrombin complex concentrate (3F-PCC) for the ability to augment thrombin generation (TG) in neonatal plasma after cardiopulmonary bypass (CPB).
